Current status and future perspectives of post-operative adjuvant therapy for gastric carcinoma

Anticancer Research

Volumn 22, Issue 1 A, 2002, Pages 283-289

  Kim, Ryungsa ^a   Yoshida, Kazuhiro ^a   Toge, Tetsuya ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Adjuvant therapy; Chemotherapy; Gastric carcinoma; Immunochemotherapy; Review

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; ALKYLATING AGENT; ANTHRACYCLINE; CARMOFUR; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IMMUNOMODULATING AGENT; IRINOTECAN; KRESTIN; LEVAMISOLE; MITOMYCIN C; PICIBANIL; SEMUSTINE; TEGAFUR; UFT; VINCA ALKALOID;

CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER IMMUNOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; GENETICS; HUMAN; META ANALYSIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAMPLE SIZE; STOMACH CARCINOMA; SURVIVAL RATE;

CHEMOTHERAPY, ADJUVANT; FORECASTING; HUMANS; IMMUNOTHERAPY; RANDOMIZED CONTROLLED TRIALS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0036253348     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Chemotherapy of gastric cancer
2. Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction
3. Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique
4. Molecular detection of disseminated cancer cells in the peripheral blood of patients with gastric cancer
5. Detection of circulating tumor cells in patients with gastrointestinal tract cancer using RT-PCR and its clinical implications
6. Concepts for systemic treatment of micrometastasis
7. Experimental evaluation of potential anticancer agents, XIII on the criteria and kinetics associated with curability of experimental leukemia
8. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials
9. Meta-analysis of adjuvant chemotherapy in gastric cancer -in reply
10. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosanegative gastric cancer: A randomized trial
11. Results of surgery for gastric cancer and effect of adjuvant mitomycin-C on cancer recurrence
12. Postoperative adjuvant chemotherapy for gastric carcinoma. Analysis of data on 1805 patients followed for 5 years
13. Postoperative adjuvant chemotherapy for gastric cancer, the second report. Analysis of data on 2873 patients followed for five years
14. Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric cancer
15. Randomized trial of adjuvant chemotherapy with mitomycin plus ftoraful versus mitomycin alone in resected locally advanced gastric cancer
16. Randomized clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage III gastric cancer
17. Mitomycin C as an adjuvant in resected gastric cancer
18. Positive results of adjuvant mitomycin-C in resected gastric cancer: A randomised trial on 134 patients
19. A randomized trial comparing adjuvant fluorouracil, doxorubicin and mitomycin with no treatment in operable gastric cancer
20. Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group Study
21. Final results of a phase III clinical study trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer
22. Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group
23. Adjuvant 5-fluorouracil and BCNU chemotherapy in gastric cancer: 3-Year results. Recent Results
24. Adjuvant chemotherapy after gastric resection in node-positive cancer patients: A multicentre randomised study
25. A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer
26. A prospective randomised evaluation of intensive course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer
27. Gastric carcinoma treated by chemotherapy after resection: A controlled study
28. Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group
29. Postoperative adjuvant 5-fluorouracil plus methyl CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group Study (EST 3275)
30. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology Group Report
31. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer
32. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: Results of a Randomized Multicenter Trial of the Austrian Working Group for Surgical Oncology
33. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer
34. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer
35. Immunochemosurgery as a new approach to reasonable treatment of advanced cancer
36. Postoperative immunochemotherapy including streptococcal OK- 432 is effective for patients with gastric cancer and serosal invasion
37. Postoperative chemotherapy including intraperitoneal and intradermal administration of the streptococcal preparation OK-432 for patients with gastric cancer and peritoneal dissemination: A prospective randomised study
38. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma
39. Expression of thymidine phosphorylase in human gastric carcinoma
40. Taxanes in combined-modality therapy for solid tumors
41. Chêmotherapy for gastric carcinoma: New and old options
42. CPT-11 in gastrointestinal cancer
43. Late phase II study of novel oral fluoropyrimidine anticancer drugs S-1 (1M tegafur 0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients
44. Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer
45. Docetaxel (Taxotere)-cisplatin (TC): An effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)
46. The treatment of advanced gastric cancer
47. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells
48. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor model in vivo
49. Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer
50. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for treatment of advanced and recurrent gastric adenocarcinoma
51. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer
52. A gene expression database for the molecular pharmacology of cancer
53. Cancer cells, chemotherapy and gene clusters
54. Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer
55. Review of adjuvant chemotherapy for gastric cancer
56. The effect of adjuvant chemotherapy in gastric carcinoma is dependent on tumor histology-5-year results of a prospective randomized trial
57. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: Interim report